SARAH REMINGTON: Open Payments
NPI 1306113550 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 12 payments from 8 companies in 2025. Trend: 2023 $94 · 2024 $449 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 2 | $164 |
| Boston Scientific Corporation | 1 | $115 |
| Amgen Inc. | 2 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| AKEBIA THERAPEUTICS INC | 2 | $49 |
| Novo Nordisk Inc | 1 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Travere Therapeutics, Inc. | 1 | $11 |
Products named: TARPEYO, WATCHMAN Access System, Fabhalta, TAVNEOS, Vafseo, Ozempic, JYNARQUE, KRYSTEXXA.
Industry payments across CO — which companies pay providers there.
